Income Statement (TTM)
Onward Medical N.V. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | -0 | 1 | 2 | 2 | 3 |
| Change (%) | 23.44 | 18.99 | 9.53 | 8.70 | 13.47 | 11.87 | 10.47 | 9.48 | -0.81 | -0.82 | -37.41 | -59.77 | -67.67 | -209.30 | -512.50 | 124.24 | 28.09 | 21.93 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 8 | 9 | 9 | 10 | 12 | 13 | 14 | 14 | 15 | 16 | 16 | 16 | 15 | 14 | 13 | 14 | 14 | 14 | 13 |
| Change (%) | 5.13 | 4.88 | 16.80 | 14.39 | 9.47 | 8.65 | 1.54 | 1.52 | 5.73 | 5.42 | -3.12 | -3.22 | -6.21 | -6.62 | 1.72 | 1.69 | -2.33 | -2.39 | |
| % of Revenue | 1,016.50 | 865.72 | 763.06 | 813.71 | 856.25 | 826.05 | 802.25 | 737.39 | 683.75 | 728.89 | 774.78 | 1,199.28 | 2,885.34 | 8,370.06 | -7,150.53 | 1,763.25 | 799.60 | 609.67 | 488.07 |
| Gross Operating Profit | -7 | -8 | -8 | -9 | -11 | -12 | -12 | -13 | -13 | -13 | -14 | -15 | -15 | -14 | -14 | -13 | -12 | -11 | -11 |
| Change (%) | 3.13 | 3.04 | 17.90 | 15.18 | 8.94 | 8.21 | 0.27 | 0.27 | 6.85 | 6.41 | 1.96 | 1.93 | -4.01 | -4.17 | -5.37 | -5.68 | -6.68 | -7.16 | |
| % of Revenue | -916.50 | -765.72 | -663.06 | -713.71 | -756.25 | -726.05 | -702.25 | -637.39 | -583.75 | -628.89 | -674.78 | -1,099.28 | -2,785.34 | -8,270.06 | 7,250.53 | -1,663.25 | -699.60 | -509.67 | -388.07 |
| SG&A | 5 | 6 | 7 | 10 | 13 | 14 | 15 | 15 | 14 | 15 | 17 | 16 | 16 | 16 | 16 | 17 | 18 | 19 | 20 |
| Change (%) | 18.23 | 15.42 | 39.21 | 28.17 | 8.72 | 8.02 | -5.59 | -5.93 | 10.24 | 9.29 | -2.48 | -2.55 | 2.05 | 2.01 | 4.72 | 4.51 | 6.93 | 6.48 | |
| % of Revenue | 676.38 | 647.85 | 628.43 | 798.72 | 941.74 | 902.30 | 871.23 | 744.52 | 639.76 | 711.05 | 783.53 | 1,220.79 | 2,957.52 | 9,334.88 | -8,711.70 | 2,211.61 | 1,030.71 | 860.40 | 751.36 |
| R&D | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Change (%) | 12.85 | 11.39 | 18.57 | 15.66 | 11.41 | 10.24 | -1.01 | -1.02 | -7.46 | -8.06 | 0.21 | 0.21 | 5.21 | 4.95 | -6.17 | -6.57 | 3.86 | 3.72 | |
| % of Revenue | 346.25 | 316.56 | 296.34 | 320.78 | 341.32 | 335.12 | 330.24 | 295.92 | 267.55 | 249.64 | 231.42 | 370.55 | 923.12 | 3,004.07 | -2,884.57 | 656.16 | 273.38 | 221.66 | 188.55 |
| OpEx | 16 | 18 | 20 | 25 | 30 | 33 | 36 | 35 | 34 | 36 | 38 | 37 | 36 | 36 | 35 | 36 | 37 | 38 | 39 |
| Change (%) | 10.79 | 9.74 | 25.46 | 20.29 | 9.45 | 8.63 | -1.98 | -2.02 | 5.33 | 5.06 | -2.41 | -2.47 | -1.04 | -1.05 | 1.90 | 1.86 | 3.01 | 2.92 | |
| % of Revenue | 2,039.12 | 1,830.13 | 1,687.83 | 1,933.22 | 2,139.31 | 2,063.46 | 2,003.72 | 1,777.83 | 1,591.06 | 1,689.58 | 1,789.73 | 2,790.62 | 6,765.98 | 20,709.01 | -18,746.81 | 4,631.01 | 2,103.68 | 1,691.74 | 1,427.98 |
| Operating Income | -16 | -17 | -19 | -24 | -29 | -31 | -34 | -33 | -32 | -34 | -36 | -36 | -35 | -35 | -35 | -35 | -35 | -35 | -36 |
| Change (%) | 10.13 | 9.20 | 26.46 | 20.92 | 9.25 | 8.47 | -2.64 | -2.71 | 5.74 | 5.43 | -0.34 | -0.34 | -0.04 | -0.04 | -0.83 | -0.84 | 1.76 | 1.73 | |
| % of Revenue | -1,939.12 | -1,730.13 | -1,587.83 | -1,833.22 | -2,039.31 | -1,963.46 | -1,903.72 | -1,677.83 | -1,491.06 | -1,589.58 | -1,689.73 | -2,690.62 | -6,665.98 | -20,609.01 | 18,846.81 | -4,531.01 | -2,003.68 | -1,591.74 | -1,327.98 |
| Interest Expense | -4 | -5 | -5 | -5 | -6 | -5 | -4 | -3 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -3 |
| Change (%) | 9.43 | 8.61 | 3.16 | 3.07 | -18.55 | -22.77 | -28.49 | -39.83 | -13.14 | -15.12 | 11.59 | 10.39 | -16.61 | -19.91 | 57.67 | 36.58 | 25.90 | 20.57 | |
| % of Revenue | -553.62 | -490.78 | -448.00 | -421.95 | -400.07 | -287.18 | -198.25 | -128.34 | -70.53 | -61.77 | -52.86 | -94.25 | -258.65 | -667.15 | 488.83 | -186.85 | -113.80 | -111.85 | -110.60 |
| Net Income | -20 | -22 | -24 | -29 | -34 | -36 | -38 | -35 | -33 | -34 | -36 | -36 | -36 | -36 | -35 | -35 | -36 | -37 | -39 |
| Change (%) | 9.91 | 9.02 | 21.54 | 17.73 | 4.70 | 4.49 | -6.35 | -6.78 | 5.01 | 4.78 | 0.17 | 0.17 | -1.42 | -1.44 | 0.82 | 0.81 | 4.10 | 3.93 | |
| % of Revenue | -2,501.75 | -2,227.59 | -2,040.94 | -2,264.76 | -2,452.75 | -2,263.06 | -2,113.63 | -1,791.79 | -1,525.70 | -1,615.37 | -1,706.53 | -2,731.19 | -6,800.94 | -20,736.05 | 18,697.34 | -4,569.70 | -2,054.34 | -1,669.49 | -1,423.09 |
Source: Capital IQ
